Dataset Information

First-row transition-metal complexes of a new pentadentate ligand, alpha,alpha,alpha',alpha'-tetra(pyrazolyl)lutidine.

ABSTRACT: A new pentadentate ligand, alpha,alpha,alpha',alpha'-tetra(pyrazolyl)lutidine, pz 4lut, has been prepared by a CoCl 2-catalyzed rearrangement reaction between 2,6-pyridinedicarboxaldehyde and dipyrazolylthione. The coordination chemistry with some divalent first-row transition metal (Mn, Fe, Co, Ni, Cu, and Zn) chlorides has been explored. The electronic properties indicate that the new kappa (5)N ligand is a slightly stronger-field donor to Ni (2+) and Co (2+) than a related pentadentate ligand with five pyridyl donors presumably because of greater interaction between the metal and axial pyridyl.

SUBMITTER: Morin TJ

PROVIDER: S-EPMC2754785 | biostudies-literature | 2008 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

First-row transition-metal complexes of a new pentadentate ligand, alpha,alpha,alpha',alpha'-tetra(pyrazolyl)lutidine.

Morin Tyler J TJ Bennett Brian B Lindeman Sergey V SV Gardinier James R JR

Inorganic chemistry 20080806 17

A new pentadentate ligand, alpha,alpha,alpha',alpha'-tetra(pyrazolyl)lutidine, pz 4lut, has been prepared by a CoCl 2-catalyzed rearrangement reaction between 2,6-pyridinedicarboxaldehyde and dipyrazolylthione. The coordination chemistry with some divalent first-row transition metal (Mn, Fe, Co, Ni, Cu, and Zn) chlorides has been explored. The electronic properties indicate that the new kappa (5)N ligand is a slightly stronger-field donor to Ni (2+) and Co (2+) than a related pentadentate ligand ...[more]

PMID: 18681427

Similar Datasets

Project description:Inflammatory mediators constitute a recently coined term in the field of metal-based complexes with antiplatelet activities. Our strategy targets Platelet-Activating Factor (PAF) and its receptor, which is the most potent lipid mediator of inflammation. Thus, the antiplatelet (anti-PAF) potency of any substance could be exerted by inhibiting the PAF-induced aggregation in washed rabbit platelets (WRPs), which internationally is a well-accepted methodology. Herein, a series of mononuclear (mer-[Cr(pqx)Cl3(H2O]) (1), [Co(pqx)Cl2(DMF)] (2) (DMF = N,N'-dimethyl formamide), [Cu(pqx)Cl2(DMSO)] (3) (DMSO = dimethyl sulfoxide), [Zn(pqx)Cl2] (4)) and dinuclear complexes ([Mn(pqx)(H2O)2Cl2]2 (5), [Fe(pqx)Cl2]2 (6) and [Ni(pqx)Cl2]2 (7)) incorporating the 2-(2'-pyridyl)quinoxaline ligand (pqx), were biologically evaluated as inhibitors of the PAF- and thrombin-induced aggregation in washed rabbit platelets (WRPs). The molecular structure of the five-co-ordinate analog (3) has been elucidated by single-crystal X-ray diffraction revealing a trigonal bipyramidal geometry. All complexes are potent inhibitors of the PAF-induced aggregation in WRPs in the micromolar range. Complex (6) displayed a remarkable in vitro dual inhibition against PAF and thrombin, with IC50 values of 1.79 μM and 0.46 μM, respectively. Within the series, complex (5) was less effective (IC50 = 39 μM) while complex (1) was almost 12-fold more potent against PAF, as opposed to thrombin-induced aggregation. The biological behavior of complexes 1, 6 and 7 on PAF's basic metabolic enzymatic pathways reveals that they affect key biosynthetic and catabolic enzymes of PAF underlying the anti-inflammatory properties of the relevant complexes. The in vitro cytotoxic activities of all complexes in HEK293T (human embryonic kidney cells) and HeLa cells (cervical cancer cells) are described via the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The results reveal that complex 3 is the most potent within the series.

Dataset Information

First-row transition-metal complexes of a new pentadentate ligand, alpha,alpha,alpha',alpha'-tetra(pyrazolyl)lutidine.

Publications

First-row transition-metal complexes of a new pentadentate ligand, alpha,alpha,alpha',alpha'-tetra(pyrazolyl)lutidine.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets